CENTOGENE Information
Summary
CENTOGENE is a public company that has been in the industry for 19 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Andrin Oswald. Its headquarters is located at Rostock, Mecklenburg-Vorpommern, DE. The number of employees ranges from 500 to 1.0K. The annual revenue of CENTOGENE varies between 100M and 500M. Total funding of the company - $84M. To connect with CENTOGENE employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
500-1000 employees
Specialties
Biochemical diagnostic test, Genetic diagnostic test, Rare diseases, Congenital diseases, Oncogenetics, Clinical and medical interpretation of genetic data, Next Generation Sequencing, Biomarker, covid19, Whole Exome Seguencing (WES), Whole Genome Sequencing (WGS), Clinical Studies, NGS Panels, Prenatal Testing, Single Gene, SARS-CoV-2
SIC Code
2836
Founded
2006
Estimated Annual Revenue
$100M - 500M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2010 | Public Company | 1.0K - 5.0K | 389.1M | $2.2B | |
| 1988 | Privately Held | 25 - 100 | < 1M | $465M | |
| 1999 | Privately Held | 500 - 1.0K | 157.1M | $0 | |
| 1970 | Privately Held | 100 - 250 | 14.7M | $0 | |
| 2004 | - | 5000-10000 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Current employees switched from
Length of Employment
